Trademark: 79195512
Word
RIVOPHARM
Status
Dead
Status Code
709
Status Date
Friday, January 19, 2024
Serial Number
79195512
Registration Number
5234473
Registration Date
Tuesday, July 4, 2017
Mark Type
4000
Filing Date
Tuesday, July 26, 2016
Published for Opposition
Tuesday, April 18, 2017
Cancellation Date
Friday, January 19, 2024

Trademark Owner History
RIVOPHARM S.A. - Original Registrant

Classifications
5 Pharmaceutical preparations, both prescription and over-the-counter, namely, pharmaceutical preparations for peptic ulcer and gastrooesophageal reflux disease (GORD), propulsives, intestinal anti-infectives, intestinal anti-inflammatory agents, oral pharmaceutical preparations for lowering blood glucose, Vitamin A and D, mixed vitamin preparations consisting of vitamins A and D, vitamin and mineral preparations for medical use, vitamin C in the nature of ascorbic acid mixed vitamin preparations consisting partially of Vitamin C, calcium supplements, mineral supplements, anti-thrombotic agents, intravenous solutions, cardiac glycosides, class I and class III anti-arrhythmics, pharmaceutical preparations for cardiac stimulation excluding cardiac glycosides, Vasodilators used in the treatment of cardiac diseases, anti-adrenergic agents, pharmaceutical preparations for acting on arteriolar smooth muscle, Beta blocking agents, Selective calcium channel blockers, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors combined with other pharmaceutical preparations, anti-fungals for systemic use, anti-infectives and antiseptics, excluding those combined with corticosteroids, oxytocics, plain corticosteroids for systemic use, thyroid preparations, anti-thyroid preparations, tetracyclines preparations, macrolides, lincosamides and streptogramins, aminoglycoside antibacterials, quinolone antibacterials, antimycotics for systemic use, direct acting antivirals, immune sera, bacterial vaccines, alkylating agents, anti-metabolites, plant alkaloids, cytotoxic antibiotics, hormone antagonists and related agents, namely, anti-estrogens, anti-androgens and enzyme inhibitors, immunosuppressive agents, antiinflammatory and antirheumatic preparations, non-steroids in the nature of butylpyrazolidines, acetic acid derivatives, oxicams, propionic acid derivatives, fenamates, Coxibs, muscle relaxants, peripherally acting agents in the nature of curare alkaloids and choline derivatives, antigout preparations, analgesics and antipyretics preparations, anti-migraine preparations, anti-epileptic preparations, anti-cholinergic agents, dopaminergic agents, anti-psychotics, anxiolytics, hypnotics and sedatives, antidepressants, parasympathomimetics, agents for use against amoebiasis and other protozoal diseases, anti-malarial preparation, adrenergics, inhalant anesthetics, adrenergics for systemic use, antihistamines for systemic use, diuretic agents

Trademark Events
Jan 19, 2024
Cancelled Section 71
Jul 4, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Nov 3, 2017
Final Decision Transaction Processed By Ib
Oct 13, 2017
Notification Processed By Ib
Oct 10, 2017
Final Disposition Notice Sent To Ib
Oct 10, 2017
Final Disposition Processed
Oct 4, 2017
Final Disposition Notice Created, To Be Sent To Ib
Jul 4, 2017
Registered-Principal Register
Apr 18, 2017
Official Gazette Publication Confirmation E-Mailed
Apr 18, 2017
Published For Opposition
Mar 29, 2017
Notification Of Possible Opposition Sent To Ib
Mar 29, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 29, 2017
Notification Of Notice Of Publication E-Mailed
Mar 10, 2017
Law Office Publication Review Completed
Mar 6, 2017
Approved For Pub - Principal Register
Mar 6, 2017
Data Modification Completed
Mar 3, 2017
Assigned To Lie
Mar 2, 2017
Teas/Email Correspondence Entered
Mar 2, 2017
Correspondence Received In Law Office
Mar 2, 2017
Teas Response To Office Action Received
Mar 1, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 1, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 9, 2016
Refusal Processed By Ib
Nov 15, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Nov 15, 2016
Refusal Processed By Mpu
Nov 11, 2016
Application Filing Receipt Mailed
Nov 9, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Nov 8, 2016
Non-Final Action Written
Nov 7, 2016
Assigned To Examiner
Nov 7, 2016
New Application Office Supplied Data Entered
Nov 3, 2016
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24